Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
BMC Neurology|January 24, 2024
Spinal adhesive arachnoiditis in an adult patient with spinal muscular atrophy type 3 treated with intrathecal therapyJakub Ubysz, Magdalena Koszewicz, Joanna Bladowska, et al.BMC Musculoskeletal Disorders|September 2, 2025
Comorbidities in spinal muscular atrophy and their impact on the course of the underlying disease: a real-life observational studyMałgorzata Błauciak, Jakub Ubysz, Małgorzata Wieczorek, et al.Journal of Clinical Medicine|July 27, 2024
The Impact of Comorbidities and Motor Impairment on the Quality of Life of Patients with Spinal Muscular Atrophy: A Case-Control StudyMałgorzata Błauciak, Jakub Ubysz, Anna Pokryszko-Dragan, et al.Orphanet Journal of Rare Diseases|September 3, 2024
Sensory dysfunction in SMA type 2 and 3 - adaptive mechanism or concomitant target of damage?Magdalena Koszewicz, Jakub Ubysz, Edyta Dziadkowiak, et al.Pediatric Endocrinology, Diabetes, and Metabolism|February 23, 2016
[Are children from resort spa healthy? The overweight and obesity in children from Kudowa-Zdrój]Joanna Połubok, Aleksandra Gonera, Jakub Ubysz, et al.Journal of Clinical Medicine|July 28, 2026
Brain Morphological Alterations in Adults with Spinal Muscular Atrophy Types 2 and 3: A CAT12-Derived Region-Based and Surface-Based Morphometry StudyAleksandra Rubin-Starczewska, Przemysław Podgórski, Jakub Ubysz, et al.Frontiers in Neurology|July 1, 2022
Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in PolandAgata Czarnowska, Joanna Tarasiuk, Olga Zajkowska, et al.Vaccines|May 28, 2022
Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying TherapiesAgata Czarnowska, Joanna Tarasiuk, Olga Zajkowska, et al.Pageof 1